{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:50:35Z","timestamp":1790898635970,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005147","name":"Applied Basic Research Key Project of Yunnan Province","doi-asserted-by":"publisher","award":["202301AT070041"],"award-info":[{"award-number":["202301AT070041"]}],"id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005147","name":"Applied Basic Research Key Project of Yunnan Province","doi-asserted-by":"publisher","award":["202301AT070259"],"award-info":[{"award-number":["202301AT070259"]}],"id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203145"],"award-info":[{"award-number":["82203145"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112328","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:50:55Z","timestamp":1765903855000},"page":"112328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting CDK12 rescues C\/EBP\u03b2-mediated platinum and PARP inhibitor resistance in ovarian cancer"],"prefix":"10.1016","volume":"139","author":[{"given":"Jiahong","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2025.112328_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"10177","key":"10.1016\/j.cellsig.2025.112328_bb0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2025.112328_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","article-title":"Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments","volume":"77","author":"Marchetti","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.112328_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2021.08.005","article-title":"Platinum-resistant ovarian cancer: from drug resistance mechanisms to liquid biopsy-based biomarkers for disease management","volume":"77","author":"Khan","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.112328_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102255","article-title":"PARP-inhibitors in epithelial ovarian cancer: actual positioning and future expectations","volume":"99","author":"Vanacker","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112328_bb0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.trecan.2021.08.007","article-title":"Tackling PARP inhibitor resistance","volume":"7","author":"Fugger","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2025.112328_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107722","article-title":"Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets","volume":"220","author":"Nameki","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2025.112328_bb0040","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409001033","article-title":"CCAAT\/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases","volume":"11","author":"Zahnow","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112328_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13148-021-01071-z","article-title":"DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter","volume":"13","author":"Shao","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112328_bb0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jb\/mvac013","article-title":"CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells","volume":"171","author":"Okazaki","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.cellsig.2025.112328_bb0055","first-page":"9","article-title":"Targeting JUN, CEBPB, and HDAC3: a novel strategy to overcome drug resistance in hypoxic glioblastoma","author":"Gao","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112328_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/fmc-2020-0240","article-title":"The promise and current status of CDK12\/13 inhibition for the treatment of cancer","volume":"13","author":"Tadesse","year":"2021","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112328_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccell.2019.09.004","article-title":"Therapeutic targeting of CDK12\/CDK13 in triple-negative breast cancer","volume":"36","author":"Quereda","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112328_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-20-2245","article-title":"Targeting CDK12 for cancer therapy: function, mechanism, and drug discovery","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112328_bb0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-021-04027-6","article-title":"CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer","volume":"12","author":"Lei","year":"2021","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112328_bb0080","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41388-021-01788-4","article-title":"C\/EBP\u03b2 promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112328_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/ijms17030272","article-title":"Synergetic effects of PARP inhibitor AZD2281 and cisplatin in oral squamous cell carcinoma in vitro and in vivo","volume":"17","author":"Yasukawa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112328_bb0090","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41467-018-03590-5","article-title":"C\/EBPbeta enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"Suppl. 5","key":"10.1016\/j.cellsig.2025.112328_bb0095","first-page":"101","article-title":"GENT2: an updated gene expression database for normal and tumor tissues","volume":"12","author":"Park","year":"2019","journal-title":"BMC Med. Genet."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112328_bb0100","doi-asserted-by":"crossref","first-page":"D729","DOI":"10.1093\/nar\/gky1094","article-title":"Cistrome data browser: expanded datasets and new tools for gene regulatory analysis","volume":"47","author":"Zheng","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112328_bb0105","doi-asserted-by":"crossref","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","article-title":"JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles","volume":"52","author":"Rauluseviciute","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112328_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"269","key":"10.1016\/j.cellsig.2025.112328_bb0115","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112328_bb0120","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112328_bb0125","doi-asserted-by":"crossref","first-page":"D1147","DOI":"10.1093\/nar\/gkab905","article-title":"CancerSCEM: a database of single-cell expression map across various human cancers","volume":"50","author":"Zeng","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.cellsig.2025.112328_bb0130","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/MCB.01674-12","article-title":"C\/EBP\u03b3 suppresses senescence and inflammatory gene expression by heterodimerizing with C\/EBP\u03b2","volume":"33","author":"Huggins","year":"2013","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112328_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2019.02.070","article-title":"A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion","volume":"511","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112328_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s40425-019-0701-2","article-title":"Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-kappaB signaling","volume":"7","author":"Wang","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112328_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-020-2426-z","article-title":"MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p\/AMPK\/PGC1\u03b1\/CEBPB axis to promote stemness and chemo-resistance of gastric cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112328_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5802082","article-title":"LINC00035 transcriptional regulation of SLC16A3 via CEBPB affects glycolysis and cell apoptosis in ovarian cancer","volume":"2021","author":"Yang","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.cellsig.2025.112328_bb0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omtn.2021.03.001","article-title":"lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress","volume":"24","author":"Zhou","year":"2021","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"6220","key":"10.1016\/j.cellsig.2025.112328_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112328_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/1541-7786.MCR-19-0631","article-title":"Dominant-negative ATF5 compromises cancer cell survival by targeting CEBPB and CEBPD","volume":"18","author":"Sun","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112328_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102504","article-title":"Cell-penetrating CEBPB and CEBPD leucine zipper decoys as broadly acting anti-cancer agents","volume":"13","author":"Zhou","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7734","key":"10.1016\/j.cellsig.2025.112328_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-018-0758-y","article-title":"CDK12 regulates DNA repair genes by suppressing intronic polyadenylation","volume":"564","author":"Dubbury","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112328_bb0180","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.drudis.2020.09.035","article-title":"CDK12: a potential therapeutic target in cancer","volume":"25","author":"Emadi","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112328_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109394","article-title":"Degradation of CCNK\/CDK12 is a druggable vulnerability of colorectal cancer","volume":"36","author":"Dieter","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2025.112328_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2020.09.011","article-title":"CDK12\/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer","volume":"495","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.112328_bb0195","first-page":"1","article-title":"CDK12 promotes cervical cancer progression through enhancing macrophage infiltration","volume":"2021","author":"Yang","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cellsig.2025.112328_bb0200","first-page":"7","article-title":"Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12\/13","author":"Zeng","year":"2018","journal-title":"Elife"},{"issue":"19","key":"10.1016\/j.cellsig.2025.112328_bb0205","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1158\/0008-5472.CAN-22-0222","article-title":"Dual inhibition of CDK12\/CDK13 targets both tumor and immune cells in ovarian cancer","volume":"82","author":"Cheng","year":"2022","journal-title":"Cancer Res."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:57:13Z","timestamp":1770494233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0898656825007430"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112328","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CDK12 rescues C\/EBP\u03b2-mediated platinum and PARP inhibitor resistance in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112328"}}